Skip to main navigation Skip to search Skip to main content

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

  • ISARIC4C Investigators
  • , PHOSP-COVID Collaborative Group
  • , Felicity Liew (Lead / Corresponding author)
  • , Shubha Talwar
  • , Andy Cross
  • , Brian J. Willett
  • , Sam Scott
  • , Nicola Logan
  • , Matthew K. Siggins
  • , Dawid Swieboda
  • , Jasmin K. Sidhu
  • , Claudia Efstathiou
  • , Shona C. Moore
  • , Chris Davis
  • , Noura Mohamed
  • , Jose Nunag
  • , Clara King
  • , A. A. Roger Thompson
  • , Sarah L. Rowland-Jones
  • , Annemarie B. Docherty
    • James D. Chalmers, Ling-Pei Ho, Alexander Horsley, Betty Raman, Krisnah Poinasamy, Michael Marks, Onn Min Kon, Luke Howard, Daniel G. Wootton, Susanna Dunachie, Jennifer K. Quint, Rachael A. Evans, Louise V. Wain, Sara Fontanella, Thushan I. de Silva, Antonia Ho, Ewen Harrison, J. Kenneth Baillie, Malcolm G. Semple, Christopher Brightling, Ryan S. Thwaites (Lead / Corresponding author), Lance Turtle (Lead / Corresponding author), Peter J. M. Openshaw (Lead / Corresponding author)

    Research output: Contribution to journal › Article › peer-review

    103   Link opens in a new tab Citations (Scopus)
    128 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination'. Together they form a unique fingerprint.
    Sort by

    Keyphrases

    Immunology and Microbiology